Gastric cancer: Current status of diagnosis and treatment

Tsunehiro Takahashi, Yoshiro Saikawa, Yuko Kitagawa

Research output: Contribution to journalReview article

101 Citations (Scopus)

Abstract

Gastric cancer is the second leading cause of death from malignant disease worldwide and most frequently discovered in advanced stages. Because curative surgery is regarded as the only option for cure, early detection of resectable gastric cancer is extremely important for good patient outcomes. Therefore, noninvasive diagnostic modalities such as evolutionary endoscopy and positron emission tomography are utilized as screening tools for gastric cancer. To date, early gastric cancer is being treated using minimally invasive methods such as endoscopic treatment and laparoscopic surgery, while in advanced cancer it is necessary to consider multimodality treatment including chemotherapy, radiotherapy, and surgery. Because of the results of large clinical trials, surgery with extended lymphadenectomy could not be recommended as a standard therapy for advanced gastric cancer. Recent clinical trials had shown survival benefits of adjuvant chemotherapy after curative resection compared with surgery alone. In addition, recent advances of molecular targeted agents would play an important role as one of the modalities for advanced gastric cancer. In this review, we summarize the current status of diagnostic technology and treatment for gastric cancer.

Original languageEnglish
Pages (from-to)48-63
Number of pages16
JournalCancers
Volume5
Issue number1
DOIs
Publication statusPublished - 2013 Mar 1

    Fingerprint

Keywords

  • Chemotherapy
  • Gastric cancer
  • Molecular targeted therapy
  • Radiotherapy
  • Surgery

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this